Dr. Luc Furic
Honorary
The Sir Peter MacCallum Department of Oncology
23 Scholarly works
3 Projects
HIGHLIGHTS
2021
Research Grant
Targeting cellular mechanisms that regulate the efficiency of protein synthesis to improve outcomes for men with metastatic castrate resistant prostate cancer
2020
Journal article
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy
DOI: 10.3390/cancers120820222020
Journal article
CRISP3 expression drives prostate cancer invasion and progression
DOI: 10.1530/ERC-20-00922019
Journal article
Translational offsetting as a mode of estrogen receptor alpha-dependent regulation of gene expression
DOI: 10.15252/embj.20181013232019
Journal article
mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans
DOI: 10.1172/jci.insight.992712017
Research Grant
HARNESSING SYNERGIES BETWEEN 177LUTATE THERAPY AND OLAPARIB TO IMPROVE CLINICAL OUTCOME OF MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER
2016
Research Grant
TARGETING RIBOSOME SYNTHESIS AND FUNCTION TO TREAT ADVANCED PROSTATE CANCER
RECENT SCHOLARLY WORKS
2019
Journal article
V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN loss.
DOI: 10.18632/oncotarget.270752019
Journal article
Generally applicable transcriptome-wide analysis of translation using anota2seq
DOI: 10.1093/nar/gkz2232019
Conference Proceedings
Cysteine-rich secretory protein 3 expression leads to invasive prostate cancer by modulating cell motility
DOI: 10.1158/1538-7445.AM2019-1552019
Journal article
A balancing act: PHLPP2 fine tunes AKT activity and MYC stability in prostate cancer
DOI: 10.1083/jcb.2019041192019
Journal article
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer
DOI: 10.1126/scitranslmed.aau57582018
Journal article
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy
DOI: 10.1016/j.eururo.2018.06.0202018
Conference Proceedings
The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer.
2018
Conference Proceedings
Estrogen receptor alpha coordinates homeostatic gene expression programs via translational buffering.